The fused cancer cells demonstrated more intense mesenchymal cell features, i.e., higher expression of POSTN, GDF11, IGFBP5 and CXCL11, and down-regulation of DAPK1, as well as greater proliferation and viability. The gene discussed is POSTN; the disease is cancer.